Related references
Note: Only part of the references are listed.Human indoleamine 2,3-dioxygenase-2 has substrate specificity and inhibition characteristics distinct from those of indoleamine 2,3-dioxygenase-1
Georgios Pantouris et al.
AMINO ACIDS (2014)
Antitumour agents as inhibitors of tryptophan 2,3-dioxygenase
Georgios Pantouris et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Indoleamine 2,3-dioxygenase (IDO) is frequently expressed in stromal cells of Hodgkin lymphoma and is associated with adverse clinical features: a retrospective cohort study
Ji-Young Choe et al.
BMC CANCER (2014)
Vitamins B2 and B6 as determinants of kynurenines and related markers of interferon-γ-mediated immune activation in the community-based Hordaland Health Study
Despoina Theofylaktopoulou et al.
BRITISH JOURNAL OF NUTRITION (2014)
Immunoregulatory Impact of Food Antioxidants
Johanna Gostner et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation
Richard Metz et al.
INTERNATIONAL IMMUNOLOGY (2014)
IDO2 Is a Critical Mediator of Autoantibody Production and Inflammatory Pathogenesis in a Mouse Model of Autoimmune Arthritis
Lauren M. F. Merlo et al.
JOURNAL OF IMMUNOLOGY (2014)
Aryl hydrocarbon receptor control of a disease tolerance defence pathway
Alban Bessede et al.
NATURE (2014)
Immune changes and neurotransmitters: Possible interactions in depression?
Barbara Sperner-Unterweger et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
The neuroimmune basis of fatigue
Robert Dantzer et al.
TRENDS IN NEUROSCIENCES (2014)
Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR
Ulrike M. Litzenburger et al.
ONCOTARGET (2014)
Indoleamine 2,3-dioxygenase inhibitors: a patent review (2008-2012)
Eduard Dolusic et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
CTLA4-Ig immunosuppressive activity at the level of dendritic cell/T cell crosstalk
Edda Mayer et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
Redox regulation of the immune response
Johanna M. Gostner et al.
REDOX REPORT (2013)
Immunomodulatory effects in vitro of vitamin K antagonist acenocoumarol
S. Schroecksnadel et al.
THROMBOSIS RESEARCH (2013)
Indoleamine 2,3 dioxygenase and metabolic control of immune responses
David H. Munn et al.
TRENDS IN IMMUNOLOGY (2013)
The Kynurenine Pathway in Stem Cell Biology
Simon P. Jones et al.
INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH (2013)
Kynurenic acid in human renal cell carcinoma: its antiproliferative and antimigrative action on Caki-2 cells
Katarzyna Walczak et al.
AMINO ACIDS (2012)
Indoleamine 2,3-dioxygenase, Tregs and Cancer
D. H. Munn
CURRENT MEDICINAL CHEMISTRY (2012)
High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma
Jocelyne Jacquemier et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
New functions of protein kinase Gcn2 in yeast and mammals
Jose R. Murguia et al.
IUBMB LIFE (2012)
Kynurenines in the mammalian brain: when physiology meets pathology
Robert Schwarcz et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior
Ebrahim Haroon et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
Luc Pilotte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Antimalarial drug chloroquine counteracts activation of indoleamine (2,3)-dioxygenase activity in human PBMC
Johanna M. Gostner et al.
FEBS OPEN BIO (2012)
The aryl hydrocarbon receptor in tumor immunity
Michael Platten et al.
ONCOIMMUNOLOGY (2012)
Indoleamine 2,3-Dioxygenase Expression in Human Cancers: Clinical and Immunologic Perspectives
Jessica Godin-Ethier et al.
CLINICAL CANCER RESEARCH (2011)
Using an Ancient Tool for Igniting and Propagating Immune Tolerance: IDO as an Inducer and Amplifier of Regulatory T Cell Functions
F. Fallarino et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Association between increased tryptophan degradation and depression in cancer patients
Katharina Kurz et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2011)
Possible Roles of Excess Tryptophan Metabolites in Cancer
King-Thom Chung et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2011)
In vitro testing for anti-inflammatory properties of compounds employing peripheral blood mononuclear cells freshly isolated from healthy donors
M. Jenny et al.
INFLAMMATION RESEARCH (2011)
Tryptophan 2,3-Dioxygenase (TDO) Inhibitors. 3-(2-(Pyridyl)ethenyl)indoles as Potential Anticancer Immunomodulators
Eduard Dolusic et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
Kynurenic acid synthesis and kynurenine aminotransferases expression in colon derived normal and cancer cells
Katarzyna Walczak et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Influence of immunosuppressive agents on tryptophan degradation and neopterin production in human peripheral blood mononuclear cells
Sebastian Schroecksnadel et al.
TRANSPLANT IMMUNOLOGY (2011)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation
Jiangbin Ye et al.
EMBO JOURNAL (2010)
Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds
Tiziana Di Pucchio et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Interferon-γ-mediated pathways are induced in human CD34+ haematopoietic stem cells
Katharina Kurz et al.
IMMUNOBIOLOGY (2010)
Tryptophan metabolite 3-hydroxyanthranilic acid selectively induces activated T cell death via intracellular GSH depletion
Sun-Mi Lee et al.
IMMUNOLOGY LETTERS (2010)
An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells
Joshua D. Mezrich et al.
JOURNAL OF IMMUNOLOGY (2010)
Rational Design of Indoleamine 2,3-Dioxygenase Inhibitors
Ute F. Roehrig et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism
Stefan Loeb et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival
Jonathan R. Brody et al.
CELL CYCLE (2009)
Prognostic value of indoleamine 2,3-dioxygenase expression in high grade osteosarcoma
Hiroshi Urakawa et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway
Helen J. Ball et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells
Babak Baban et al.
JOURNAL OF IMMUNOLOGY (2009)
Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond
Vadivel Ganapathy et al.
PHARMACOLOGY & THERAPEUTICS (2009)
High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome
M. E.D. Chamuleau et al.
HAEMATOLOGICA (2008)
Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma
Ke Pan et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
Marc Veldhoen et al.
NATURE (2008)
Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
Francisco J. Quintana et al.
NATURE (2008)
Human tryptophan dioxygenase: A comparison to indoleamine 2,3-dioxygenase
Dipanwita Batabyal et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma
Rainer Riesenberg et al.
CLINICAL CANCER RESEARCH (2007)
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis
Tolmoko Hayashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The Gcn2 kinase as a cell cycle regulator
Beata Grallert et al.
CELL CYCLE (2007)
Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice
Helen J. Ball et al.
GENE (2007)
Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients
Georg Weinlich et al.
DERMATOLOGY (2007)
Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer
K. Ino et al.
BRITISH JOURNAL OF CANCER (2006)
Antitumoral activity of interferon-γ involved in impaired immune function in cancer patients
Gerald Brandacher et al.
CURRENT DRUG METABOLISM (2006)
Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation
DH Munn
CURRENT OPINION IN IMMUNOLOGY (2006)
Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer:: Effect on tumor-infiltrating T cells
G Brandacher et al.
CLINICAL CANCER RESEARCH (2006)
Monitoring tryptophan metabolism in chronic immune activation
K Schröcksnadel et al.
CLINICA CHIMICA ACTA (2006)
Tryptophan degradation in patients with gynecological cancer correlates with immune activation
K Schroecksnadel et al.
CANCER LETTERS (2005)
GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase
DH Munn et al.
IMMUNITY (2005)
Aspirin down-regulates tryptophan degradation in stimulated human peripheral blood mononuclear cells in vitro
K Schroecksnadel et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Indoleamine 2,3-dioxygenase: distribution and function in the developing human placenta
Y Kudo et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2004)
Possible role of cytokine-induced tryptophan degradation in anaemia of inflammation
G Weiss et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2004)
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation
R Meisel et al.
BLOOD (2004)
Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase
AL Mellor et al.
INTERNATIONAL IMMUNOLOGY (2004)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Neopterin production, tryptophan degradation, and mental depression - What is the link?
B Widner et al.
BRAIN BEHAVIOR AND IMMUNITY (2002)
T cell apoptosis by tryptophan catabolism
I Fallarino et al.
CELL DEATH AND DIFFERENTIATION (2002)
Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer
A Huang et al.
BRITISH JOURNAL OF CANCER (2002)
Neopterin as a marker for immune system activation
C Murr et al.
CURRENT DRUG METABOLISM (2002)
Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus
AK Khanna
TRANSPLANTATION (2000)
Share Paper
